These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3563981)

  • 41. The influence of drugs on disseminated intravascular coagulation (dic). III. Effects of busulfan-induced thrombocytopenia and inhibition of platelet function by acetylsalicylic acid.
    Markwardt F; Nowak G; Glusa E; Hoffman A
    Thromb Res; 1979; 15(1-2):79-88. PubMed ID: 483284
    [No Abstract]   [Full Text] [Related]  

  • 42. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphological alterations of blood platelets induced by platelet activating factor (PAF) and partial inhibition by ketoprofen in calves.
    Bastos da Silva M; Dessy C; David JL; Lekeux P
    Vet Res; 1997; 28(5):489-502. PubMed ID: 9342825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model.
    Taguchi K; Ujihira H; Watanabe H; Fujiyama A; Doi M; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    J Pharm Sci; 2013 Oct; 102(10):3852-9. PubMed ID: 23918456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of radionuclide-labeled platelets and fibrinogen in paraquat-damaged rat lungs.
    Divertie MB; Owen CA; Barham SS; Ludwig J
    Am Rev Respir Dis; 1982 May; 125(5):574-8. PubMed ID: 7081818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid.
    Mandal S; Stoner GD
    Carcinogenesis; 1990 Jan; 11(1):55-61. PubMed ID: 2295128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombocytopenia in experimental trypanosomiasis.
    Davis CE; Robbins RS; Weller RD; Braude AI
    J Clin Invest; 1974 May; 53(5):1359-67. PubMed ID: 4207622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe thrombocytopenia delays but does not prevent the occlusion of an arterial prosthesis in rats.
    Reyers I; Mussoni L; Donati MB; de Gaetano G
    Thromb Haemost; 1981 Aug; 46(2):558-60. PubMed ID: 7053224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
    Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
    Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
    Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
    J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid.
    Mandal S; Ahuja A; Shivapurkar NM; Cheng SJ; Groopman JD; Stoner GD
    Carcinogenesis; 1987 Nov; 8(11):1651-6. PubMed ID: 3117405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of preoperative treatment with aspirin or heparin on platelet function and intensity of postoperative bleeding in early period after coronary artery bypass surgery].
    Veikutiene A; Sirvinskas E; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V
    Medicina (Kaunas); 2005; 41(7):577-83. PubMed ID: 16062025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.